STOCK TITAN
  1. Home
  2. Sec-filings
  3. PRVA
  4. [Form 4] Privia Health Group, Inc. Insider Trading Activity

Privia Health director granted 6,350 RSUs

A Privia Health Group director received 6,350 time-vested restricted stock units tied to the 2027 annual meeting.

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Privia Health Group, Inc. (symbol: PRVA) is the issuer of record for a Form 4 filing submitted to the SEC. Ernest Opella Finley reported acquisition or exercise transactions in this Form 4 filing.

Privia Health Group, Inc. (PRVA) reported that director Ernest Opella Finley received an award of 6,350 shares of common stock in the form of restricted stock units. The grant was made at $0.00 per share under the company’s 2021 Omnibus Incentive Plan and represents his entire reported direct holding after this award. According to the grant terms, these restricted stock units will become fully vested on the day immediately preceding the date of the company’s 2027 Annual Meeting of Stockholders. No Rule 10b5-1 trading plan is reported for this award.

Positive

  • None.

Negative

  • None.
Insider Ernest Opella Finley
Role Director
Type Security Shares Price Value
Grant/Award Common Stock, $0.01 par value per share F1 6,350 $0.00 $0.00
Holdings After Transaction: Common Stock, $0.01 par value per share — 6,350 shares (Direct)
Footnotes (1)
  1. F1. Represents restricted stock units granted under the Issuer's 2021 Omnibus Incentive Plan that will become fully vested on the day immediately preceding the date of Company's 2027 Annual Meeting of Stockholders.
Restricted stock units granted 6,350 shares Grant to director Ernest Opella Finley on September 1, 2026
Grant price per share $0.00 per share Restricted stock unit award under 2021 Omnibus Incentive Plan
Shares held after transaction 6,350 shares Director Ernest Opella Finley’s direct holdings following the award
Vesting reference date Day immediately preceding 2027 Annual Meeting Date when the restricted stock units become fully vested
restricted stock units financial
"Represents restricted stock units granted under the Issuer's 2021 Omnibus Incentive Plan"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
2021 Omnibus Incentive Plan financial
"restricted stock units granted under the Issuer's 2021 Omnibus Incentive Plan"
Annual Meeting of Stockholders financial
"fully vested on the day immediately preceding the date of Company's 2027 Annual Meeting"

FAQ

What insider equity award was reported at PRVA in this Form 4?
The filing reports that director Ernest Opella Finley received 6,350 restricted stock units of Privia Health Group, Inc. common stock as a grant or award acquisition, with a stated price of $0.00 per share under the company’s 2021 Omnibus Incentive Plan.

When do the new PRVA restricted stock units for the director vest?
The 6,350 restricted stock units granted to director Ernest Opella Finley will become fully vested on the day immediately preceding the date of Privia Health Group, Inc.’s 2027 Annual Meeting of Stockholders, as specified in the award footnote.

How many PRVA shares does the director hold after this reported transaction?
After the reported grant, director Ernest Opella Finley holds 6,350 shares of Privia Health Group, Inc. common stock in the form of restricted stock units, reported as direct ownership following the transaction.

Was the PRVA insider transaction made under a Rule 10b5-1 trading plan?
No. The Form 4 indicates the Rule 10b5-1 checkbox is not checked, and no footnote describes a pre-arranged trading plan, so this restricted stock unit grant is not reported as made under a Rule 10b5-1 plan.

What type of security did the PRVA director acquire in this Form 4?
Director Ernest Opella Finley acquired restricted stock units representing shares of Common Stock, $0.01 par value per share of Privia Health Group, Inc., under the company’s 2021 Omnibus Incentive Plan.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Ernest Opella Finley
(Last)(First)(Middle)
950 N. GLEBE ROAD
SUITE 700
(Street)
ARLINGTON VIRGINIA 22203
(City)(State)(Zip)
UNITED STATES
(Country)		2. Issuer Name and Ticker or Trading Symbol
Privia Health Group, Inc. [ PRVA ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
09/01/2026		6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock, $0.01 par value per share09/01/2026A6,350(1)A$06,350D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. Represents restricted stock units granted under the Issuer's 2021 Omnibus Incentive Plan that will become fully vested on the day immediately preceding the date of Company's 2027 Annual Meeting of Stockholders.
Remarks:
/s/ Anita Beth Adams, as attorney-in-fact09/03/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR